CYTORI THERAPEUTICS INC - COM (CYTX)

CUSIP: 23283K105

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
13,672,670
Share change
-56,459
Total reported value
$35,153,575
Put/Call ratio
177%
Price per share
$2.57
Number of holders
71
Value change
-$149,938
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 23283K105?
CUSIP 23283K105 identifies CYTX - CYTORI THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM (CYTX) as of Q4 2013

As of 31 Dec 2013, CYTORI THERAPEUTICS INC - COM (CYTX) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,672,670 shares. The largest 10 holders included BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, NORTHERN TRUST CORP, State Street Corp, PERKINS CAPITAL MANAGEMENT INC, Goldman Capital Management Inc, PRINCETON CAPITAL MANAGEMENT INC, Bank of New York Mellon Corp, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 71 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.